SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-13-000405
Filing Date
2013-03-14
Accepted
2013-03-14 16:30:13
Documents
2
Period of Report
2013-03-12

Document Format Files

Seq Description Document Type Size
1 form3-03142013_040302.html 3  
1 form3-03142013_040302.xml 3 1659
2 ex24-03142013_040302.htm EX-24 3770
  Complete submission text file 0001415889-13-000405.txt   7146
Mailing Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103
Business Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103 215-717-4100
Echo Therapeutics, Inc. (Issuer) CIK: 0001031927 (see all company filings)

IRS No.: 411649949 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address C/O DUSA PHARMACEUTICALS, INC. 25 UPTON DRIVE WILMINGTON MA 01887
Business Address
Doman Robert F (Reporting) CIK: 0001313163 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35218 | Film No.: 13690836